The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.
本发明涉及用于抑制线粒体
氧化
磷酸化(OXPH
OS)的
胍啉化合物及其使用。更具体地,本发明涉及一种用于预防或治疗与OXPH
OS相关的疾病,特别是通过抑制线粒体
氧化
磷酸化和重编程细胞代谢的药物组合物。